The Growing Spectrum of Cutaneous RASopathy

Maurice A. M. van Steensel

doi:10.1016/j.jid.2015.10.059

The Growing Spectrum of Cutaneous RASopathy

Maurice A. M. van Steensel (Lead / Corresponding author)

Research output: Contribution to journal › Comment/debate › peer-review

3 Citations (Scopus)

Abstract

Groesser et al. demonstrate that pyogenic granuloma is a RAS pathway-driven tumor. This important observation adds yet another manifestation to the growing spectrum of cutaneous "RASopathies" and raises intriguing questions about the relationship between RAS pathway activation and malignancy.

Original language	English
Pages (from-to)	359-360
Number of pages	2
Journal	Journal of Investigative Dermatology
Volume	136
Issue number	2
Early online date	20 Jan 2016
DOIs	https://doi.org/10.1016/j.jid.2015.10.059
Publication status	Published - Feb 2016

Access to Document

10.1016/j.jid.2015.10.059

Cite this

@article{222bcf90fb31469a97e86737a71c1adf,

title = "The Growing Spectrum of Cutaneous RASopathy",

abstract = "Groesser et al. demonstrate that pyogenic granuloma is a RAS pathway-driven tumor. This important observation adds yet another manifestation to the growing spectrum of cutaneous {"}RASopathies{"} and raises intriguing questions about the relationship between RAS pathway activation and malignancy.",

author = "{van Steensel}, {Maurice A. M.}",

year = "2016",

month = feb,

doi = "10.1016/j.jid.2015.10.059",

language = "English",

volume = "136",

pages = "359--360",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - The Growing Spectrum of Cutaneous RASopathy

AU - van Steensel, Maurice A. M.

PY - 2016/2

Y1 - 2016/2

N2 - Groesser et al. demonstrate that pyogenic granuloma is a RAS pathway-driven tumor. This important observation adds yet another manifestation to the growing spectrum of cutaneous "RASopathies" and raises intriguing questions about the relationship between RAS pathway activation and malignancy.

AB - Groesser et al. demonstrate that pyogenic granuloma is a RAS pathway-driven tumor. This important observation adds yet another manifestation to the growing spectrum of cutaneous "RASopathies" and raises intriguing questions about the relationship between RAS pathway activation and malignancy.

UR - http://www.scopus.com/inward/record.url?scp=84973578477&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2015.10.059

DO - 10.1016/j.jid.2015.10.059

M3 - Comment/debate

C2 - 26802231

AN - SCOPUS:84973578477

SN - 0022-202X

VL - 136

SP - 359

EP - 360

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 2

ER -

The Growing Spectrum of Cutaneous RASopathy

Abstract

Access to Document

Other files and links

Fingerprint

Cite this